Back to search

Article

Immune Microenvironment and Clinical Significance of PD1 Expression in Hepatocellular Carcinoma Patients

2022-02-02

Abstract excerpt

Immune checkpoint inhibitors (ICI) have revolutionized treatment for hepatocellular carcinoma (HCC), however, durable response is limited to only a subset of patients. Therefore, this study aims to identify the ICI-responsive HCC patients and to investigate the distribution of programmed death 1 (PD1) in HCC patients, as well as the relationship among PD1, pathological parameters and survival of HCC patients. A to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36ef752f-0f5a-5324-9810-eb4ca6010123
DOI
10.21203/rs.3.rs-1257996/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immune Microenvironment and Clinical Significance of PD1 Expression in Hepatocellular Carcinoma PatientsDOI 10.21203/rs.3.rs-1257996/v1
Select a neighboring publication to make it the new centre.